Xiangjurupining Capsule

· Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xiangjurupining Capsule, covering 2024-09-05 to 2024-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands [Phase 3]